Acousana® Therapy, a groundbreaking approach to treating chronic pain, utilizes SoftWave® technology. This non-invasive treatment has been transforming the landscape of pain management and tissue regeneration, offering a compelling alternative to traditional pain relief methods.
Understanding SoftWave® Technology
SoftWave technology is at the forefront of medical innovation, utilizing electrohydraulic acoustic shockwave devices for tissue regeneration and pain management. This patented technology generates shockwaves through a high-energy electrical discharge in water. The process involves voltage discharge between the electrode’s tips, creating a hot plasma bubble which explodes, compresses the surrounding water, and generates a pressure wave. This wave, known as a SoftWave, is low intensity and unfocused, yet highly effective in penetrating tissues without causing microtrauma.
The SoftWave device’s patented parabolic reflector applicator design is a key component of this technology. It allows for the generation of primary and secondary waves, spreading energy across a large tissue area, both superficially and deeply, to solicit a biological response. This unique design ensures a wide and deep penetration of the shockwave, significantly differentiating it from other focused devices or radial pressure wave technologies.
Acousana Therapy: A Game Changer in Pain Management
Acousana Therapy, powered by SoftWave technology, is revolutionizing the approach to chronic pain treatment. This therapy triggers a cellular response upon delivery, activating the body’s natural healing process. The benefits include increased blood supply, promotion of angiogenesis, modulation of inflammation, activation of resident stem cells, restoration of tissue elasticity, and activation of endogenous growth factors.
The SoftWave Difference: Unfocused Shockwave
SoftWave’s unfocused shockwave approach is distinct from conventional radial pressure waves and ultrasound therapies. Unlike radial devices that produce shallow waves with high energy at the applicator’s surface, SoftWave’s true shockwaves are characterized by high positive pressure, fast and steep rise time, followed by a comparatively small negative pressure. This difference is crucial in achieving effective and safe treatment outcomes, particularly in a wider and deeper treatment area.
Acousana vs. other “Shockwave Technologies”
It’s essential to differentiate between Acousana therapy and other shockwave technologies. Most other technologies such as focused or radial therapy, uses high-frequency, low-intensity sound waves, mainly targeting surface-level tissues. It’s less invasive and suitable for light soft tissue injuries and conditions. In contrast, SoftWave technology, as used in Acousana, delivers sound waves that penetrate deeper, making it more effective for harder tissue injuries and chronic conditions.
FDA Clearance and Applications
SoftWave technology is FDA 510(k) cleared for various indications, including activation of connective tissue, treatment of chronic diabetic foot ulcers, acute second-degree burns, improved blood supply, and pain relief. This clearance underlines the technology’s safety and effectiveness for a range of medical conditions.
Acousana Therapy, through its use of SoftWave technology, offers a promising option for individuals suffering from chronic pain. Its non-invasive nature, coupled with its ability to initiate biological regeneration at the cellular level, makes it an attractive option for pain management. As we continue to see advancements in medical technology, Acousana Therapy stands out as a beacon of hope for those seeking relief from chronic pain conditions.
Ready to experience relief from chronic pain? Contact our certified professionals today to explore how Acousana Therapy can transform your life.